Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Nov '24 Nov 20, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019 - 2015
Market Capitalization	38	29	24	50	120	25	Upgrade
Market Cap Growth	5.60%	21.85%	-52.44%	-58.30%	390.26%	-49.66%	Upgrade
Enterprise Value	72	72	80	94	162	27	Upgrade
Last Close Price	1.53	1.22	1.19	2.51	6.30	2.00	Upgrade
PE Ratio	-	-	19.87	-	-	-	Upgrade
PS Ratio	0.46	0.26	0.22	0.65	1.51	0.44	Upgrade
PB Ratio	1.47	0.96	1.06	2.82	6.68	1.01	Upgrade
P/FCF Ratio	2.18	1.56	-	-	24.45	-	Upgrade
P/OCF Ratio	2.17	1.55	-	-	23.88	-	Upgrade
EV/Sales Ratio	0.71	0.64	0.74	1.23	2.04	0.49	Upgrade
EV/EBITDA Ratio	4.02	3.91	5.59	-	25.52	11.14	Upgrade
EV/EBIT Ratio	5.84	5.64	9.46	-	221.81	-	Upgrade
EV/FCF Ratio	3.28	3.86	-	-	32.94	-	Upgrade
Debt / Equity Ratio	1.31	1.65	3.12	3.08	2.49	1.60	Upgrade
Debt / EBITDA Ratio	2.31	2.68	4.81	-	6.69	13.91	Upgrade
Debt / FCF Ratio	1.94	2.67	-	-	9.11	-	Upgrade
Asset Turnover	0.67	0.71	0.72	0.53	0.59	0.55	Upgrade
Inventory Turnover	1.40	1.79	1.92	1.83	2.24	2.31	Upgrade
Quick Ratio	0.32	0.44	0.42	0.51	0.94	0.59	Upgrade
Current Ratio	1.01	1.09	0.87	1.02	1.47	1.16	Upgrade
Return on Equity (ROE)	8.42%	-0.81%	6.07%	-16.08%	-133.65%	-18.55%	Upgrade
Return on Assets (ROA)	5.14%	5.04%	3.53%	-5.38%	0.34%	-0.70%	Upgrade
Return on Capital (ROIC)	9.45%	9.25%	6.42%	-11.41%	0.73%	-1.35%	Upgrade
Earnings Yield	5.71%	-0.74%	5.12%	-5.74%	-23.48%	-19.15%	Upgrade
FCF Yield	45.83%	64.18%	-6.31%	-2.54%	4.09%	-7.36%	Upgrade
Buyback Yield / Dilution	-18.66%	-9.56%	-3.36%	-30.65%	-5.83%	-44.92%	Upgrade
Total Shareholder Return	-18.66%	-9.56%	-3.36%	-30.65%	-5.83%	-44.92%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.